Nizar Ahmad

Summary

Country: France

Publications

  1. ncbi Geographical representativeness of published and ongoing randomized controlled trials. The example of: Tobacco consumption and HIV infection
    Nizar Ahmad
    INSERM, U738, Paris, France
    PLoS ONE 6:e16878. 2011
  2. ncbi Applicability and generalisability of the results of systematic reviews to public health practice and policy: a systematic review
    Nizar Ahmad
    Centre d Epidemiologie Clinique, Hopital Hotel Dieu, AP HP Assistance Publique des Hôpitaux de Paris, 1 Place du Parvis Notre Dame, Paris 75181, France
    Trials 11:20. 2010
  3. ncbi Reporting of safety results in published reports of randomized controlled trials
    Isabelle Pitrou
    Département d Epidémiologie, Biostatistique, et Recherche Clinique, Groupe Hospitalier Bichat Claude Bernard AP HP, Universite Denis Diderot, INSERM U738, Paris, France
    Arch Intern Med 169:1756-61. 2009
  4. ncbi Neglected external validity in reports of randomized trials: the example of hip and knee osteoarthritis
    Nizar Ahmad
    INSERM U738, Assistance Publique Hopitaux de Paris, Hopital Bichat Claude Bernard, Universite Paris 7, Paris, France
    Arthritis Rheum 61:361-9. 2009

Collaborators

Detail Information

Publications4

  1. ncbi Geographical representativeness of published and ongoing randomized controlled trials. The example of: Tobacco consumption and HIV infection
    Nizar Ahmad
    INSERM, U738, Paris, France
    PLoS ONE 6:e16878. 2011
    ..This study aimed to compare where research is conducted to where research is needed for 2 public health priorities: tobacco consumption and HIV infection...
  2. ncbi Applicability and generalisability of the results of systematic reviews to public health practice and policy: a systematic review
    Nizar Ahmad
    Centre d Epidemiologie Clinique, Hopital Hotel Dieu, AP HP Assistance Publique des Hôpitaux de Paris, 1 Place du Parvis Notre Dame, Paris 75181, France
    Trials 11:20. 2010
    ..e., whether the results of a trial can be reasonably applied or generalized to a definable group of patients in a particular setting in routine practice, also called external validity or generalisability)...
  3. ncbi Reporting of safety results in published reports of randomized controlled trials
    Isabelle Pitrou
    Département d Epidémiologie, Biostatistique, et Recherche Clinique, Groupe Hospitalier Bichat Claude Bernard AP HP, Universite Denis Diderot, INSERM U738, Paris, France
    Arch Intern Med 169:1756-61. 2009
    ..Poor safety reporting can lead to misinterpretation and inadequate conclusions about the interventions assessed. Our aim was to describe the reporting of harm-related results from randomized controlled trials (RCTs)...
  4. ncbi Neglected external validity in reports of randomized trials: the example of hip and knee osteoarthritis
    Nizar Ahmad
    INSERM U738, Assistance Publique Hopitaux de Paris, Hopital Bichat Claude Bernard, Universite Paris 7, Paris, France
    Arthritis Rheum 61:361-9. 2009
    ..To evaluate data reporting related to external validity from randomized controlled trials (RCTs) assessing pharmacologic and nonpharmacologic treatment for hip and knee osteoarthritis (OA)...